Top Markets
Coin of the day
Vasamed, Inc. Vasamed, Inc.

Vasamed, Inc.

VSMD
Classificação em ações #42568
Vasamed, Inc. specializes in the development, manufacturing, licensing, and... Vasamed, Inc. specializes in the development, manufacturing, licensing, and distribution of a comprehensive suite of products, software solutions, and services focused on the assessment and management of circulatory health throughout the United States. Key among its offerings is the SensiLase PAD-IQ, a device designed to measure skin perfusion pressure, conduct pulse volume recordings, and calculate the Ankle-Brachial Index utilizing Doppler-derived pressure readings. The company also provides advanced Wound Imaging & SmartDraw systems for precise wound measurement. Additionally, Vasamed offers the PAD-IQ Studycast, a platform that facilitates the rapid and secure transmission of diagnostic test results to vascular specialists. This enables prompt interpretation of findings and supports timely, medically indicated therapeutic interventions. For safeguarding its equipment, the company also supplies a custom carrying case for the PAD-IQ system. Vasamed caters to both clinicians and patients, and has been operating since its founding in 1988. Its corporate headquarters are located in Eden Prairie, Minnesota.
Preço da ação
$0.0001
Última sincronização: 2026-08-11
Valor de mercado
$802.00
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Vasamed, Inc. (VSMD)

Categoria

Lucros da Vasamed, Inc. (VSMD)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Vasamed, Inc., os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Vasamed, Inc. de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
$3.81B -
US
$4.11B -
FR
- -
JP
$1.59B -
US
- -
CH